Gastric cancer: evidence boosts Helicobacter pylori eradication

Hidekazu Suzuki; Juntaro Matsuzaki

doi:10.1038/s41575-018-0023-8

Gastric cancer: evidence boosts Helicobacter pylori eradication

Hidekazu Suzuki
, Juntaro Matsuzaki

医学教育統轄センター

研究成果: Article › 査読

27 被引用数 (Scopus)

抄録

The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.

本文言語	English
ページ（範囲）	458-460
ページ数	3
ジャーナル	Nature Reviews Gastroenterology and Hepatology
巻	15
号	8
DOI	https://doi.org/10.1038/s41575-018-0023-8
出版ステータス	Published - 2018 8月 1

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

ASJC Scopus subject areas

肝臓学
消化器病学

文献へのアクセス

10.1038/s41575-018-0023-8

他のファイルとリンク

引用スタイル

@article{b617c46b3ede4cdea8344b192c5c8a4c,

title = "Gastric cancer: evidence boosts Helicobacter pylori eradication",

abstract = "The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.",

author = "Hidekazu Suzuki and Juntaro Matsuzaki",

note = "Publisher Copyright: {\textcopyright} 2018, Macmillan Publishers Ltd., part of Springer Nature.",

year = "2018",

month = aug,

day = "1",

doi = "10.1038/s41575-018-0023-8",

language = "English",

volume = "15",

pages = "458--460",

journal = "Nature Reviews Gastroenterology and Hepatology",

issn = "1759-5045",

publisher = "Nature Research",

number = "8",

}

TY - JOUR

T1 - Gastric cancer

T2 - evidence boosts Helicobacter pylori eradication

AU - Suzuki, Hidekazu

AU - Matsuzaki, Juntaro

PY - 2018/8/1

Y1 - 2018/8/1

N2 - The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.

AB - The efficacy of Helicobacter pylori eradication therapy for the prevention of preneoplastic lesions in gastric cancer remains controversial. A new placebo-controlled trial and a large-scale observational study tackle this problem and show the positive effects of eradication therapy.

UR - https://www.scopus.com/pages/publications/85046106631

UR - https://www.scopus.com/pages/publications/85046106631#tab=citedBy

U2 - 10.1038/s41575-018-0023-8

DO - 10.1038/s41575-018-0023-8

M3 - Article

C2 - 29713024

AN - SCOPUS:85046106631

SN - 1759-5045

VL - 15

SP - 458

EP - 460

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

IS - 8

ER -

Gastric cancer: evidence boosts Helicobacter pylori eradication

抄録

UN SDG

ASJC Scopus subject areas

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル